WO2004020595A3 - Nouveaux polypeptides humains codes par des polynucleotides - Google Patents

Nouveaux polypeptides humains codes par des polynucleotides Download PDF

Info

Publication number
WO2004020595A3
WO2004020595A3 PCT/US2003/027107 US0327107W WO2004020595A3 WO 2004020595 A3 WO2004020595 A3 WO 2004020595A3 US 0327107 W US0327107 W US 0327107W WO 2004020595 A3 WO2004020595 A3 WO 2004020595A3
Authority
WO
WIPO (PCT)
Prior art keywords
polynucleotides
polypeptides encoded
novel human
human polypeptides
modulators
Prior art date
Application number
PCT/US2003/027107
Other languages
English (en)
Other versions
WO2004020595A2 (fr
WO2004020595A8 (fr
Inventor
Lewis T Williams
Keting Chu
Ernestine Lee
Kevin Hestir
Original Assignee
Five Prime Therapeutics Inc
Riken The Inst Of Physical And
Dnaform Kk
Williams Lews T
Keting Chu
Ernestine Lee
Kevin Hestir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Five Prime Therapeutics Inc, Riken The Inst Of Physical And, Dnaform Kk, Williams Lews T, Keting Chu, Ernestine Lee, Kevin Hestir filed Critical Five Prime Therapeutics Inc
Priority to AU2003274935A priority Critical patent/AU2003274935A1/en
Publication of WO2004020595A2 publication Critical patent/WO2004020595A2/fr
Publication of WO2004020595A8 publication Critical patent/WO2004020595A8/fr
Publication of WO2004020595A3 publication Critical patent/WO2004020595A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Cette invention se rapporte à de nouveaux polynucléotides, à des polypeptides associés, à des compositions d'acides nucléiques et de polypeptides associées, et à des modulateurs associés tels que des anticorps et des modulateurs de petites molécules. Ces compositions sont utiles pour traiter les affections prolifératives, telles que les cancers, les affections inflammatoires immunes, bactériennes et virales.
PCT/US2003/027107 2002-08-29 2003-08-28 Nouveaux polypeptides humains codes par des polynucleotides WO2004020595A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003274935A AU2003274935A1 (en) 2002-08-29 2003-08-28 Novel human polypeptides encoded by polynucleotides

Applications Claiming Priority (68)

Application Number Priority Date Filing Date Title
US40657602P 2002-08-29 2002-08-29
US40661202P 2002-08-29 2002-08-29
US40665502P 2002-08-29 2002-08-29
US40661602P 2002-08-29 2002-08-29
US40666602P 2002-08-29 2002-08-29
US40664002P 2002-08-29 2002-08-29
US40661102P 2002-08-29 2002-08-29
US60/406,666 2002-08-29
US60/406,612 2002-08-29
US60/406,640 2002-08-29
US60/406,576 2002-08-29
US60/406,611 2002-08-29
US60/406,616 2002-08-29
US60/406,655 2002-08-29
US41095102P 2002-09-17 2002-09-17
US41104602P 2002-09-17 2002-09-17
US41103702P 2002-09-17 2002-09-17
US41096002P 2002-09-17 2002-09-17
US41096202P 2002-09-17 2002-09-17
US41095702P 2002-09-17 2002-09-17
US41094602P 2002-09-17 2002-09-17
US41105202P 2002-09-17 2002-09-17
US41095302P 2002-09-17 2002-09-17
US41102202P 2002-09-17 2002-09-17
US41101902P 2002-09-17 2002-09-17
US41102402P 2002-09-17 2002-09-17
US41111102P 2002-09-17 2002-09-17
US41108202P 2002-09-17 2002-09-17
US60/411,022 2002-09-17
US60/410,946 2002-09-17
US60/410,957 2002-09-17
US60/411,019 2002-09-17
US60/411,046 2002-09-17
US60/411,024 2002-09-17
US60/410,953 2002-09-17
US60/410,951 2002-09-17
US60/410,960 2002-09-17
US60/411,082 2002-09-17
US60/411,052 2002-09-17
US60/411,037 2002-09-17
US60/410,962 2002-09-17
US60/411,111 2002-09-17
US46370003P 2003-04-18 2003-04-18
US46373203P 2003-04-18 2003-04-18
US60/463,700 2003-04-18
US60/463,732 2003-04-18
US46723003P 2003-05-02 2003-05-02
US46720303P 2003-05-02 2003-05-02
US60/467,230 2003-05-02
US60/467,203 2003-05-02
US47130603P 2003-05-19 2003-05-19
US60,471,306 2003-05-19
US47242003P 2003-05-22 2003-05-22
US60/472,420 2003-05-22
US47660903P 2003-06-09 2003-06-09
US60/476,609 2003-06-09
US48532503P 2003-07-08 2003-07-08
US48522303P 2003-07-08 2003-07-08
US60/485,223 2003-07-08
US60/485,325 2003-07-08
US48648003P 2003-07-14 2003-07-14
US60/486,480 2003-07-14
US48696003P 2003-07-15 2003-07-15
US60/486,960 2003-07-15
US49357303P 2003-08-08 2003-08-08
US49337003P 2003-08-08 2003-08-08
US60/493,573 2003-08-08
US60/493,370 2003-08-08

Publications (3)

Publication Number Publication Date
WO2004020595A2 WO2004020595A2 (fr) 2004-03-11
WO2004020595A8 WO2004020595A8 (fr) 2004-07-15
WO2004020595A3 true WO2004020595A3 (fr) 2006-05-04

Family

ID=32686486

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/027107 WO2004020595A2 (fr) 2002-08-29 2003-08-28 Nouveaux polypeptides humains codes par des polynucleotides

Country Status (1)

Country Link
WO (1) WO2004020595A2 (fr)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101438983B1 (ko) 2003-11-06 2014-09-05 시애틀 지네틱스, 인크. 리간드에 접합될 수 있는 모노메틸발린 화합물
AU2005249490B2 (en) 2004-06-01 2010-07-29 Genentech, Inc. Antibody drug conjugates and methods
US20100111856A1 (en) 2004-09-23 2010-05-06 Herman Gill Zirconium-radiolabeled, cysteine engineered antibody conjugates
PL1791565T3 (pl) 2004-09-23 2016-10-31 Modyfikowane cysteiną przeciwciała i koniugaty
MX2008013756A (es) * 2006-05-05 2009-03-26 Universiteit Maastricht Carim Peptidos para uso en el diagnostico de la presencia de lesiones ateroscleroticas rotas en un individuo.
JP5728743B2 (ja) * 2009-03-30 2015-06-03 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 関節リウマチの診断のためのバイオマーカー、方法およびキット
US8470980B2 (en) 2009-09-09 2013-06-25 Centrose, Llc Extracellular targeted drug conjugates
WO2011130598A1 (fr) 2010-04-15 2011-10-20 Spirogen Limited Pyrrolobenzodiazépines et conjugués de celles-ci
MX336540B (es) 2010-06-08 2016-01-22 Genentech Inc Conjugados y anticuerpos manipulados geneticamente con cisteina.
CA2816426A1 (fr) 2010-11-17 2012-06-07 Genentech, Inc. Conjugues d'anticorps alaninyl-maytansinol
CA2833212C (fr) 2011-05-12 2020-06-09 Genentech, Inc. Reaction multiple de surveillance du procede lc-ms/ms pour detecter les anticorps therapeutiques dans les echantillons d'animaux par des peptides de signature du cadre
US11135303B2 (en) 2011-10-14 2021-10-05 Medimmune Limited Pyrrolobenzodiazepines and conjugates thereof
WO2013130093A1 (fr) 2012-03-02 2013-09-06 Genentech, Inc. Biomarqueurs pour un traitement à base de composés chimiothérapeutiques anti-tubuline
CN105102003B (zh) 2012-10-12 2019-03-05 Adc疗法责任有限公司 吡咯并苯并二氮杂卓-抗psma抗体结合物
WO2014057114A1 (fr) 2012-10-12 2014-04-17 Adc Therapeutics Sàrl Conjugués pyrrolobenzodiazepine-anticorps anti-psma
MX364328B (es) 2012-10-12 2019-04-23 Medimmune Ltd Conjugados del anticuerpo pirrolobenzodiazepina.
JP6392765B2 (ja) 2012-10-12 2018-09-19 エイディーシー・セラピューティクス・エス・アーＡｄｃ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｓａ ピロロベンゾジアゼピン−抗体結合体
EP2839860B1 (fr) 2012-10-12 2019-05-01 MedImmune Limited Pyrrolobenzodiazépines et ses conjugués
EP2906297B1 (fr) 2012-10-12 2017-12-06 ADC Therapeutics SA Conjugués anticorps - pyrrolobenzodiazépine
CA2887895C (fr) 2012-10-12 2019-10-29 Adc Therapeutics Sarl Conjugues d'anticorps cd19-anti-pyrrolobenzodiazepine
WO2014096365A1 (fr) 2012-12-21 2014-06-26 Spirogen Sàrl Dimères de pyrrolobenzodiazépines asymétriques à utiliser dans le traitement de maladies prolifératives et auto-immunes
AU2013366493B2 (en) 2012-12-21 2017-08-24 Medimmune Limited Pyrrolobenzodiazepines and conjugates thereof
BR112015021965B1 (pt) 2013-03-13 2022-05-03 Medimmune Limited Conjugados e compostos de pirrolobenzodiazepinas, composição farmacêutica, uso dos mesmos para o tratamento de uma doença proliferativa e método de síntese dos ditos compostos
KR102057755B1 (ko) 2013-03-13 2019-12-19 메디뮨 리미티드 피롤로벤조디아제핀 및 그의 컨쥬게이트
JP6444902B2 (ja) 2013-03-13 2018-12-26 メドイミューン・リミテッドＭｅｄＩｍｍｕｎｅ Ｌｉｍｉｔｅｄ ピロロベンゾジアゼピン及びその結合体
EA201690195A1 (ru) 2013-08-12 2016-05-31 Дженентек, Инк. Конъюгатные соединения антитело-лекарство на основе димера 1-(хлорметил)-2,3-дигидро-1h-бензо[e]индола и способы применения и лечения
EP3054983B1 (fr) 2013-10-11 2019-03-20 Medimmune Limited Conjugués anticorps-pyrrolobenzodiazépines
EP3054985B1 (fr) 2013-10-11 2018-12-26 Medimmune Limited Conjugués anticorps-pyrrolobenzodiazépine
US9956299B2 (en) 2013-10-11 2018-05-01 Medimmune Limited Pyrrolobenzodiazepine—antibody conjugates
GB201317982D0 (en) 2013-10-11 2013-11-27 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
RU2689388C1 (ru) 2013-12-16 2019-05-28 Дженентек, Инк. Пептидомиметические соединения и их конъюгаты антител с лекарственными средствами
CN105828840B (zh) 2013-12-16 2020-08-04 基因泰克公司 1-(氯甲基)-2,3-二氢-1H-苯并[e]吲哚二聚体抗体-药物缀合物化合物及使用和治疗方法
CA2933557A1 (fr) 2013-12-16 2015-06-25 Genentech, Inc. Composes peptidomimetiques et conjugues anticorps-medicament de ceux-ci
US10188746B2 (en) 2014-09-10 2019-01-29 Medimmune Limited Pyrrolobenzodiazepines and conjugates thereof
EP3191521A2 (fr) 2014-09-12 2017-07-19 F. Hoffmann-La Roche AG Anticorps et conjugués modifiés génétiquement avec de la cystéine
CN106714844B (zh) 2014-09-12 2022-08-05 基因泰克公司 蒽环类二硫化物中间体、抗体-药物缀合物和方法
GB201416112D0 (en) 2014-09-12 2014-10-29 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
PE20170905A1 (es) 2014-09-17 2017-07-12 Genentech Inc Pirrolobenzodiazepinas y conjugados de anticuerpo-disulfuro de las mismas
CA2968447A1 (fr) 2014-11-25 2016-06-02 Adc Therapeutics Sa Conjugues anticorps-pyrrolobenzodiazepine
CN107206101B (zh) 2014-12-03 2021-06-25 基因泰克公司 季铵化合物及其抗体-药物缀合物
GB201506411D0 (en) 2015-04-15 2015-05-27 Bergenbio As Humanized anti-axl antibodies
GB201506402D0 (en) 2015-04-15 2015-05-27 Berkel Patricius H C Van And Howard Philip W Site-specific antibody-drug conjugates
MA43345A (fr) 2015-10-02 2018-08-08 Hoffmann La Roche Conjugués anticorps-médicaments de pyrrolobenzodiazépine et méthodes d'utilisation
MA43354A (fr) 2015-10-16 2018-08-22 Genentech Inc Conjugués médicamenteux à pont disulfure encombré
MA45326A (fr) 2015-10-20 2018-08-29 Genentech Inc Conjugués calichéamicine-anticorps-médicament et procédés d'utilisation
GB201601431D0 (en) 2016-01-26 2016-03-09 Medimmune Ltd Pyrrolobenzodiazepines
GB201602356D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201602359D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
JP6943872B2 (ja) 2016-03-25 2021-10-06 ジェネンテック， インコーポレイテッド 多重全抗体及び抗体複合体化薬物定量化アッセイ
GB201607478D0 (en) 2016-04-29 2016-06-15 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
PL3458101T3 (pl) 2016-05-20 2021-05-31 F. Hoffmann-La Roche Ag Koniugaty PROTAC-przeciwciało i sposoby ich stosowania
CN109313200B (zh) 2016-05-27 2022-10-04 豪夫迈·罗氏有限公司 用于表征位点特异性抗体-药物缀合物的生物分析性方法
JP7043425B2 (ja) 2016-06-06 2022-03-29 ジェネンテック， インコーポレイテッド シルベストロール抗体－薬物コンジュゲート及び使用方法
JP7093767B2 (ja) 2016-08-11 2022-06-30 ジェネンテック， インコーポレイテッド ピロロベンゾジアゼピンプロドラッグ及びその抗体コンジュゲート
CN110139674B (zh) 2016-10-05 2023-05-16 豪夫迈·罗氏有限公司 制备抗体药物缀合物的方法
GB201617466D0 (en) 2016-10-14 2016-11-30 Medimmune Ltd Pyrrolobenzodiazepine conjugates
GB201702031D0 (en) 2017-02-08 2017-03-22 Medlmmune Ltd Pyrrolobenzodiazepine-antibody conjugates
JP6671555B2 (ja) 2017-02-08 2020-03-25 アーデーセー セラピューティクス ソシエテ アノニム ピロロベンゾジアゼピン抗体複合体
JP2020517609A (ja) 2017-04-18 2020-06-18 メディミューン リミテッド ピロロベンゾジアゼピン複合体
CA3057748A1 (fr) 2017-04-20 2018-10-25 Adc Therapeutics Sa Polytherapie avec un conjugue anticorps anti-axl-medicament
WO2018229222A1 (fr) 2017-06-14 2018-12-20 Adc Therapeutics Sa Régimes posologiques pour l'administration d'un cam anti-cd19
WO2019034764A1 (fr) 2017-08-18 2019-02-21 Medimmune Limited Conjugués de pyrrolobenzodiazépine
JP2020534300A (ja) 2017-09-20 2020-11-26 ピーエイチ・ファーマ・カンパニー・リミテッドＰｈ Ｐｈａｒｍａ Ｃｏ．， Ｌｔｄ． タイランスタチン類似体
GB201803342D0 (en) 2018-03-01 2018-04-18 Medimmune Ltd Methods
GB201806022D0 (en) 2018-04-12 2018-05-30 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
GB201814281D0 (en) 2018-09-03 2018-10-17 Femtogenix Ltd Cytotoxic agents
WO2020086858A1 (fr) 2018-10-24 2020-04-30 Genentech, Inc. Inducteurs chimiques conjugués de dégradation et méthodes d'utilisation
WO2020123275A1 (fr) 2018-12-10 2020-06-18 Genentech, Inc. Peptides de photoréticulation pour conjugaison spécifique de site à des protéines contenant fc
KR102351041B1 (ko) * 2018-12-19 2022-01-13 한국화학연구원 인간 lrrc24 단백질 유래 세포막 투과 도메인
GB201901197D0 (en) 2019-01-29 2019-03-20 Femtogenix Ltd G-A Crosslinking cytotoxic agents
CN111259667A (zh) * 2020-01-16 2020-06-09 上海国民集团健康科技有限公司 一种中医分词算法
GB2597532A (en) 2020-07-28 2022-02-02 Femtogenix Ltd Cytotoxic compounds

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6365344B1 (en) * 1996-01-23 2002-04-02 The Board Of Trustees Of The Leland Stanford Junior University Methods for screening for transdominant effector peptides and RNA molecules
US6426186B1 (en) * 2000-01-18 2002-07-30 Incyte Genomics, Inc Bone remodeling genes

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6365344B1 (en) * 1996-01-23 2002-04-02 The Board Of Trustees Of The Leland Stanford Junior University Methods for screening for transdominant effector peptides and RNA molecules
US6426186B1 (en) * 2000-01-18 2002-07-30 Incyte Genomics, Inc Bone remodeling genes

Also Published As

Publication number Publication date
WO2004020595A2 (fr) 2004-03-11
WO2004020595A8 (fr) 2004-07-15

Similar Documents

Publication Publication Date Title
WO2004020595A8 (fr) Nouveaux polypeptides humains codes par des polynucleotides
WO2004035732A3 (fr) Polypeptides humains codes par des polynucleotides et procedes d'utilisation de ces polypeptides
IL161016A (en) Polypeptides capable of ang-2 binding
WO2002024909A3 (fr) Acides nucleiques et polypeptides de nouveau recepteur
WO2000040614A3 (fr) Caracterisation d'une famille de canaux calciques
EP1005540A4 (fr) Proteines ikk-beta, acides nucleiques et procedes
HK1120556A1 (en) Neurotrophic factors
WO2003020932A1 (fr) Nouvelles proteines de secretion et adn associe
WO2003018758A3 (fr) Reactifs et methodes utilises dans des therapies du muscle lisse
WO2004093804A3 (fr) Polypeptides humains codes par des polynucleotides et methodes d'utilisation associees
WO2004087874A3 (fr) Acides nucleiques et polypeptides
WO2004099388A3 (fr) Complexes de polypeptides cbl-b et methodes associees
MXPA03006218A (es) Receptor de citosina tipo 2 y acidos nucleicos que codifican para lo mismo.
WO2005085280A3 (fr) Clones d'adnc humains comportant des polynucleotides et leurs procedes d'utilisation
WO2004094651A3 (fr) Nouveaux polypeptides humains codes par des polynucleotides
WO2004020591A3 (fr) Methodes d'utilisation de nouveaux polypeptides humains codes par des polynucleotides
WO2004038003A3 (fr) Polypeptides humains codes par des polynucleotides et methodes d'utilisation
WO2005037236A3 (fr) Nouveaux polypeptides associes a la proteine de choc thermique 20 et utilisations
WO2003055980A3 (fr) Molecules du type il-17 et utilisations associees
WO2004039952A8 (fr) Procedes d'utilisation de polypeptides humains codes par des polynucleotides
WO2004039319A3 (fr) Nouveaux polypeptides humains codes par des polynucleotides
WO2004046310A3 (fr) Nouveaux polypeptides de souris codes par des polynucleotides et leurs procedes d'utilisation
WO2004078130A3 (fr) Proteines d'interaction posh et procedes connexes
WO2004089302A3 (fr) Polypeptides posh, complexes et procedes correspondants
WO2002072632A3 (fr) Acides nucleiques du gene abcc11 humain, vecteurs contenant lesdits acides nucleiques et leurs utilisations

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 11/2004 UNDER (30) ADD "60/463,732 18 APRIL 2003 (18.04.2003) US; 60/463,700 18 APRIL 2003 (18.04.2003) US; 60/467,230 02 MAY 2003 (02.05.2003) US; 60/467,203 02 MAY 2003 (02.05.2003) US; 60/471,306 19 MAY 2003 (19.05.2003) US; 60/472,420 22 MAY 2003 (22.05.2003) US; 60/476,609 09 JUNE 2003 (09.06.2003) US; 60/485,223 08 JULY 2003 (08.07.2003) US; 60/485,325 08 JULY 2003 (08.07.2003) US; 60/486,480 14 JULY 203 (14.07.2003) US; 60/486,960 15 JULY 2003 (15.07.2003) US; 60/493,573 08 AUGUST 2003 (08.08.2003) US; 60/493,370 08 AUGUST 2003 (08.08.2003) US"

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP